MSFS
BIIB icon

Main Street Financial Solutions’s Biogen BIIB Stock Holding History

Main Street Financial Solutions’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-728
Closed -$202K – 447
2022
Q4 		$202K Buy
+728
New +$206K 0.03% 416

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Main Street Financial Solutions's BIIB Position: Q1 2023 in Review

Main Street Financial Solutions sold out of Biogen (BIIB) in Q1 2023, closing a stake of 728 shares — an estimated $202K sold.

Main Street Financial Solutions first reported a position in BIIB in Q4 2022 and held it in 1 quarter. The position peaked at $202K in Q4 2022. 1,001 funds tracked by Wall St. Rank hold BIIB as of Q1 2023.

  • Main Street Financial Solutions reported no remaining Biogen position as of Q1 2023 after selling out during the quarter.
  • Main Street Financial Solutions sold 728 Biogen shares in Q1 2023, an estimated $202K.
  • Main Street Financial Solutions first reported a position in Biogen in Q4 2022 and held it in 1 quarter.
  • Main Street Financial Solutions's Biogen position peaked at $202K in Q4 2022.
  • 1,001 funds tracked by Wall St. Rank held Biogen as of Q1 2023.

Based on Main Street Financial Solutions's 13F filing for Q1 2023, filed 21 Apr 2023.